World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
104
Citations
38794
World Ranking
617
National Ranking
361

Medicine

D-Index
105
Citations
39719
World Ranking
6786
National Ranking
3582

Overview

David M. Margolis is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research focuses primarily on medicine, with a significant emphasis on immunology and microbiology.

Their work extensively covers subfields such as infectious diseases, virology, immunology, molecular biology, and epidemiology.

Key research topics include

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Immune Cell Function and Interaction
  • HIV-related health complications and treatments
  • SARS-CoV-2 and COVID-19 Research
  • Cytomegalovirus and herpesvirus research

Their frequent collaborators are

  • Nancie M. Archin
  • Joseph J. Eron
  • Edward P. Browne
  • Cynthia L. Gay
  • JoAnn Kuruc

David M. Margolis has contributed to numerous publications, with notable venues including

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Virology
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Selected recent papers authored or co-authored by David M. Margolis include:

  • "SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract" (2020, Cell)
  • "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo" (2020, Science)
  • "The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients" (2020, Science Immunology)
  • "Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women" (2021, New England Journal of Medicine)
  • "Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo" (2020, Nature)

Best Publications

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary

  • The challenge of finding a cure for HIV infection.

    Douglas D. Richman;David M. Margolis;Martin Delaney;Warner C. Greene

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

    Lakshmanane Premkumar;Bruno Segovia-Chumbez;Ramesh Jadi;David R. Martinez

  • Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.

    Elizabeth A Worthey;Alan N Mayer;Alan N Mayer;Grant D Syverson;Daniel Helbling

  • Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

    Ginger Lehrman;Ian B Hogue;Sarah Palmer;Cheryl Jennings

  • Effect of NASA light-emitting diode irradiation on wound healing.

    Harry T. Whelan;Robert L. Smits;Ellen V. Buchman;Noel T. Whelan

  • Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

    Francois Raffi;Anita Rachlis;Hans-Jürgen Stellbrink;W David Hardy

  • Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy.

    Janis T. Eells;Margaret T.T. Wong-Riley;James VerHoeve;Michele Henry

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

    David A. Margolis;Juan Gonzalez-Garcia;Hans Jürgen Stellbrink;Joseph J. Eron

  • Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

    Susan Swindells;Jaime-Federico Andrade-Villanueva;Gary J. Richmond;Giuliano Rizzardini

  • Clinical and experimental applications of NIR-LED photobiomodulation.

    Kristina D Desmet;David A Paz;Jesse J Corry;Janis T Eells

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.

    Celsa A. Spina;Celsa A. Spina;Jenny Anderson;Nancie M. Archin;Alberto Bosque

  • Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report

    Mark C. Walters;Rainer Storb;Melinda Patience;Wendy Leisenring

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

    Chloe Orkin;Keikawus Arasteh;Miguel Górgolas Hernández-Mora;Vadim Pokrovsky

  • Inhibition of HIV Fusion with Multivalent Gold Nanoparticles

    Mary Catherine Bowman;T. Eric Ballard;Christopher J. Ackerson;Daniel L. Feldheim

  • Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

    Amanda M. Crooks;Rosalie Bateson;Anna B. Cope;Noelle P. Dahl

  • The Human Factors YY1 and LSF Repress the Human Immunodeficiency Virus Type 1 Long Terminal Repeat via Recruitment of Histone Deacetylase 1

    Jason J. Coull;Fabio Romerio;Jian Min Sun;Janet L. Volker

  • Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid

    Nancie M. Archin;Amy Espeseth;Daniel Parker;Manzoor Cheema

Frequent Co-Authors

Nancie M. Archin
Nancie M. Archin University of North Carolina at Chapel Hill
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Guido Ferrari
Guido Ferrari Duke University
Ronald J. Bosch
Ronald J. Bosch Harvard University
Guido Silvestri
Guido Silvestri Emory University
Barton F. Haynes
Barton F. Haynes Duke University
John W. Mellors
John W. Mellors University of Pittsburgh
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
John M. Coffin
John M. Coffin Tufts University
Robert F. Siliciano
Robert F. Siliciano Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields through online programs can open diverse career pathways. Accelerated nursing programs offer a swift transition into the nursing profession. If you're searching for options, consider looking for accelerated nursing programs near me to find convenient, fast-track routes.

For those starting their nursing journey, finding the right Licensed Practical Nurse program is crucial. Understanding which LPN programs are easiest to get into can help aspiring nurses select schools that match their goals and academic preparation.

Advancing further, many students explore nurse practitioner degrees to expand their clinical expertise. Identifying the easiest online nurse practitioner programs can provide flexible learning options while balancing other commitments.

Specializing in mental health? Online Psychiatric Mental Health Nurse Practitioner programs stand out for clinical placement success. Researching the best PMHNP programs online is key for securing valuable hands-on experience.

Best Scientists Citing David M. Margolis

Trending Scientists

Recently Published Articles